BassieNL schreef op 4 maart 2019 19:08:
[...]
Ik verwacht dezelfde outlook die telkens wordt afgegeven:
- continued growth in revenues from sales
- positive quarterly net earnings
- investment in the expansion of production
- investment in further clinical trial programs
- ...
- no further financial guidance for 2018 is provided